Anti-COVID Pills – New Chapter In Fight Against Coronavirus
Anti-COVID pills are taken orally when a person shows symptoms of COVID-19 inorder to avoid serious forms of the illness, and therefore hospitalisation. After many months of research, Merck and Pfizer say that they have reached their goal. Merck and Pfizer said that clinical trials showed a great reduction in the risk of hospitalisation. The risk of admission into hospitals by the COVID-19 patients who have taken Molnupiravir developed by Merck and Paxlovid as soon as the first coronavirus symptoms appear, reduced by 50 per cent and 90 per cent respectively. According to a study published in October by Brazilian researchers in the Lancet Global Health journal, Fluvoxamine also showed good results in preventing serious forms of COVID-19.
“The success of these antivirals potentially marks a new era in our ability to prevent the severe consequences of SARS-CoV2 infection,” British virologist Stephen Griffin told the Science Media Center. If these pills prove to be successful then the patient can take it easily at home and this is going to be a new chapter in fight against COVID-19 pandemic. Merck and Pfizer’s treatments didn’t show any side effects so far.
We all know that the United Kingdom has already given green signal for the use of Merck’s Molnupiravir in patients at risk of developing a serious form of the illness.